| Next month » |
31-Jan-2003 - German LION bioscience has launched an integration platform that aims to speed up drug discovery by integrating cross-functional information from a variety of databases and...
30-Jan-2003 - US Valentis announced that its wholly-owned subsidiary, PolyMASC Pharmaceuticals, has received a favourable ruling from the Japanese Patent Office in regard to patent invalidation proceedings...
28-Jan-2003 - AAC Consulting Group, the regulatory consulting subsidiary of contract research organisation Kendle International, has signed an agreement with two toxicologists - Gary Flamm and James...
28-Jan-2003 - Canadian drug development company Ecopia BioSciences on Monday announced that it had filed patent applications for the first two novel compounds using its proprietary drug...
28-Jan-2003 - As in-licensing opportunities are reduced and competition for market share in Japan increases with the rising penetration of western pharma companies, domestic mid-cap players must...
28-Jan-2003 - London zoo was the setting last week for UK inspection body Select QA to formally receive certification from the United Kingdom Accreditation Service, involving the...
28-Jan-2003 - Alcan Pharma Center, a US division of flexible packaging unit Alcan Packaging, has installed a new four colour Rotomec 3000-5 ES gravure printing press, with...
11-Jan-2003 - US company Molecular Devices, a supplier of bioanalytical measurement systems, announced its revenues and earnings for the quarter and year ended 31 December, 2002. Revenues...
11-Jan-2003 - King Pharmaceuticals is to buy the rights to two of Elan Corp.'s drugs in the United States and Puerto Rico for $850 million. The purchase...
10-Jan-2003 - Franco-German drugmaker Aventis and Germany's Bayer have agreed not to pursue their plans to create a joint venture in the field of biological products. The...
09-Jan-2003 - Emerson Process Management has received a multi-year contract from Voridian, a division of Eastman Chemical, to upgrade automation systems at Voridian's polyethylene terephthalate (PET) polymers...
07-Jan-2003 - German chemicals company Degussa has sold its Frankfurt/Main-based biopharmaceutical company Zentaris to Canadian firm AEterna Laboratories for approximately €50 million, the company said last week....
06-Jan-2003 - French chemicals company Rhodia is to sell its UK-based brewing and enzymes businesses to US biotech company Genencor International in a bid to strengthen its...
| Next month » |
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference